Schell, M., Pflüger, I., Brugnara, G., Isensee, F., Neuberger, U., Foltyn, M., . . . Kickingereder, P. (2020). Validation of diffusion MRI phenotypes for predicting response to bevacizumab in recurrent glioblastoma: Post-hoc analysis of the EORTC-26101 trial. Neuro Oncol.
Styl ChicagoSchell, Marianne, et al. "Validation of Diffusion MRI Phenotypes for Predicting Response to Bevacizumab in Recurrent Glioblastoma: Post-hoc Analysis of the EORTC-26101 Trial." Neuro Oncol 2020.
Citace podle MLASchell, Marianne, et al. "Validation of Diffusion MRI Phenotypes for Predicting Response to Bevacizumab in Recurrent Glioblastoma: Post-hoc Analysis of the EORTC-26101 Trial." Neuro Oncol 2020.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..